Precision oncology seeks to leverage molecular information about cancer to improve patient
outcomes. Tissue biopsy samples are widely used to characterize tumours but are limited by …

The management of patients with metastatic renal cell carcinoma (RCC) has changed
dramatically over the past few years. Nephrectomy remains an important intervention for …

Abstract Purpose: Cell-free DNA (cfDNA) sequencing provides a noninvasive method for
obtaining actionable genomic information to guide personalized cancer treatment, but the …

Abstract “Liquid biopsy” approaches analyzing cell-free DNA (cfDNA) from the blood of
patients with cancer are increasingly utilized in clinical practice. However, it is not yet known …

Liquid biopsy, particularly the analysis of circulating tumor DNA (ctDNA), has demonstrated
considerable promise for numerous clinical intended uses. Successful validation and …

Examination of tumor molecular characteristics by liquid biopsy is likely to greatly influence
personalized cancer patient management. Analysis of circulating tumor DNA (ctDNA) …

Introduction: Cancer statistics show that recent improvements in cancer management are
only mildly effective in the absence of reliable biomarkers for the detection, diagnosis and …

Abstract Background About 25–37% of resectable pancreatic ductal adenocarcinoma
(PDAC) had a great chance of early recurrence after radical resection, which is mainly due …

Liquid biopsy, an innovative method for early diagnosis of cancer, has changed the
traditional method of diagnosing lung cancer and is considered a feasible auxiliary …

Liquid biopsy has the potential to drastically change clinical practice, paving the way to a
novel non-invasive approach for cancer diagnosis and treatment. One of the limitations for …